Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 3,462 $ 2,361
Restricted cash 25 173
Accounts receivable, net 4,203 5,824
Inventories, net 5,420 6,580
Prepaid expenses and other current assets 3,317 2,641
Total Current Assets 16,427 17,579
Property and equipment, net 321 417
Right-of-use assets, operating leases 801 951
Intangible assets, net 13,878 14,641
Goodwill 18,614 18,614
Other assets 687 1,330
Total Assets 50,728 53,532
Current Liabilities    
Short term loan, net 18,157 16,061
Line of credit, net 5,687 4,819
PPP loans 333 0
Other liabilities 209 500
Accounts payable 4,044 4,049
Accrued liabilities 4,731 4,721
Deferred revenue 354 311
Operating lease liability, current portion 341 345
Warrant derivative liability 4,315 2,220
Total Current Liabilities 38,171 33,026
Noncurrent Liabilities    
Notes payable, net 17,594 16,370
PPP loans 519 0
Operating lease liability 492 641
Total Noncurrent Liabilities 18,605 17,011
Total Liabilities 56,776 50,037
Redeemable Series E Convertible Preferred Stock    
Redeemable Series E preferred stock, $0.001 par value, 2,900,000 shares authorized, 1,387,378 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 10,566 10,566
Stockholders' Deficit    
Common stock, $0.001 par value, 88,000,000 shares authorized, 48,939,708 and 47,977,390 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 49 48
Additional paid-in capital 212,532 194,150
Accumulated deficit (229,195) (201,269)
Total Stockholders' Deficit (16,614) (7,071)
Total Liabilities, Redeemable Preferred Stock and Stockholders' Deficit $ 50,728 $ 53,532